What's next for BINSA, the House bill restricting China deals

July 14, 2026 03:41 PM EDT PharmaLaw What’s the sta­tus of House law­mak­ers’ bill on Chi­na biotech re­stric­tions? Max Bayer Senior Reporter Af­ter set­ting the in­dus­try ablaze last month, a bi­par­ti­san bill aimed at re­strict­ing US biotech com­pa­nies from strik­ing deals with Chi­nese coun­ter­parts … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER